ArticleGlobal health & medicine2025
Breast cancer screening challenges in women with breast augmentation: Evidence from a comprehensive health checkup program.
Article in Global health & medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Breast augmentation may compromise the accuracy of breast cancer screening and mammography in particular. The aim of this study was to assess its impact on screening practices and the need for diagnostic follow-up. Data from 1,596 women undergoing comprehensive health checkups in 2024 were retrospectively analyzed. Among 912 women screened for breast cancer, 853 underwent both a mammography and ultrasound, while 54 underwent ultrasound only. Additional evaluation was required in 41/853 (4.8%) of the combined screening group compared to 1/54 (1.9%) of the ultrasound-only group. Breast augmentation was identified in 13/912 (1.43%) using extended detection, and 13/912 (1.43%) in the dedicated field. These findings highlight the limitations of mammography in augmented breasts. Breast augmentation influences screening choices and may hinder cancer detection. Alternative modalities, such as diffusion-weighted whole-body imaging with background body signal suppression (DWIBS) MRI or low-compression 3D mammography, should be considered to improve detection accuracy and patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.